Corvus Pharmaceuticals Inc (CRVS) is destined for greater heights as its last quarter sales were 0 K
On Tuesday, Corvus Pharmaceuticals Inc (NASDAQ: CRVS) opened higher 6.93% from the last session, before settling in for the closing price of $3.03. Price fluctuations